Paul J. Mellett
2011
In 2011, Paul J. Mellett earned a total compensation of $374K as Senior Vice President, Finance Administration and Chief Financial Officer at Enanta Pharmaceuticals.
Compensation breakdown
| Bonus | $79,452 |
|---|---|
| Option Awards | $13,203 |
| Salary | $276,914 |
| Other | $4,421 |
| Total | $373,990 |
Mellett received $276.9K in salary, accounting for 74% of the total pay in 2011.
Mellett also received $79.5K in bonus, $13.2K in option awards and $4.4K in other compensation.
Rankings
In 2011, Paul J. Mellett's compensation ranked 8,876th out of 10,747 executives tracked by ExecPay. In other words, Mellett earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,876 out of 10,747 | 17th |
Division Manufacturing | 3,305 out of 3,958 | 17th |
Major group Chemicals And Allied Products | 837 out of 1,031 | 19th |
Industry group Drugs | 617 out of 779 | 21st |
Industry Pharmaceutical Preparations | 467 out of 567 | 18th |
Source: SEC filing on January 10, 2014.
Mellett's colleagues
We found two more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2011.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019